459 related articles for article (PubMed ID: 11422762)
1. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
[TBL] [Abstract][Full Text] [Related]
2. Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.
Hovind P; Tarnow L; Rossing P; Carstensen B; Parving HH
Kidney Int; 2004 Sep; 66(3):1180-6. PubMed ID: 15327415
[TBL] [Abstract][Full Text] [Related]
3. Progression of diabetic nephropathy.
Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
Kidney Int; 2001 Feb; 59(2):702-9. PubMed ID: 11168952
[TBL] [Abstract][Full Text] [Related]
4. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
Parving HH; Hommel E; Jensen BR; Hansen HP
Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
[TBL] [Abstract][Full Text] [Related]
5. Remission of nephrotic-range albuminuria in type 1 diabetic patients.
Hovind P; Rossing P; Tarnow L; Toft H; Parving J; Parving HH
Diabetes Care; 2001 Nov; 24(11):1972-7. PubMed ID: 11679467
[TBL] [Abstract][Full Text] [Related]
6. Smoking and progression of diabetic nephropathy in type 1 diabetes.
Hovind P; Rossing P; Tarnow L; Parving HH
Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
[TBL] [Abstract][Full Text] [Related]
7. Low-protein diet and kidney function in insulin-dependent diabetic patients with diabetic nephropathy.
Hansen HP; Christensen PK; Tauber-Lassen E; Klausen A; Jensen BR; Parving HH
Kidney Int; 1999 Feb; 55(2):621-8. PubMed ID: 9987086
[TBL] [Abstract][Full Text] [Related]
8. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
Parving HH; Jacobsen P; Tarnow L; Rossing P; Lecerf L; Poirier O; Cambien F
BMJ; 1996 Sep; 313(7057):591-4. PubMed ID: 8806248
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.
Parving HH; Rossing P; Hommel E; Smidt UM
Am J Kidney Dis; 1995 Jul; 26(1):99-107. PubMed ID: 7611276
[TBL] [Abstract][Full Text] [Related]
10. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
[TBL] [Abstract][Full Text] [Related]
11. Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy.
Hansen HP; Nielsen FS; Rossing P; Jacobsen P; Jensen BR; Parving HH
Kidney Int Suppl; 1997 Dec; 63():S49-53. PubMed ID: 9407421
[TBL] [Abstract][Full Text] [Related]
12. Reduction in albuminuria predicts diminished progression in diabetic nephropathy.
Rossing P; Hommel E; Smidt UM; Parving HH
Kidney Int Suppl; 1994 Feb; 45():S145-9. PubMed ID: 8158884
[TBL] [Abstract][Full Text] [Related]
13. Evidence of a threshold value of glycated hemoglobin to improve the course of renal function in type 2 diabetes with typical diabetic glomerulopathy.
Brocco E; Velussi M; Cernigoi AM; Abaterusso C; Bruseghin M; Carraro A; Sambataro M; Piarulli F; Sfriso A; Nosadini R
J Nephrol; 2001; 14(6):461-71. PubMed ID: 11783602
[TBL] [Abstract][Full Text] [Related]
14. Remission and regression of diabetic nephropathy.
Hovind P; Tarnow L; Parving HH
Curr Hypertens Rep; 2004 Oct; 6(5):377-82. PubMed ID: 15341691
[TBL] [Abstract][Full Text] [Related]
15. Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy.
Tarnow L; Rossing P; Jensen C; Hansen BV; Parving HH
Diabetes Care; 2000 Dec; 23(12):1725-30. PubMed ID: 11128341
[TBL] [Abstract][Full Text] [Related]
16. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
[TBL] [Abstract][Full Text] [Related]
17. Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy.
Parving HH; Smidt UM; Hommel E; Mathiesen ER; Rossing P; Nielsen F; Gall MA
Am J Kidney Dis; 1993 Jul; 22(1):188-95. PubMed ID: 8322782
[TBL] [Abstract][Full Text] [Related]
18. Diabetic nephropathy and arterial hypertension. The effect of antihypertensive treatment.
Parving HH; Andersen AR; Smidt UM; Christiansen JS; Oxenbøll B; Svendsen PA
Diabetes; 1983 May; 32 Suppl 2():83-7. PubMed ID: 6400672
[TBL] [Abstract][Full Text] [Related]
19. Blood pressure reduction as a preventive treatment of diabetic nephropathy.
Ribstein J; Mimran A
Clin Invest Med; 1991 Dec; 14(6):661-70. PubMed ID: 1794216
[TBL] [Abstract][Full Text] [Related]
20. Effect of 3 years of antihypertensive therapy on renal structure in type 1 diabetic patients with albuminuria: the European Study for the Prevention of Renal Disease in Type 1 Diabetes (ESPRIT).
Diabetes; 2001 Apr; 50(4):843-50. PubMed ID: 11289051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
